425 results on '"Peghin, Maddalena"'
Search Results
2. Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use
3. Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
4. Donor-derived carbapenem-resistant gram-negative bacterial infections in solid organ transplant recipients: Active surveillance enhances recipient safety
5. Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years
6. Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19
7. Neuroinvasive West Nile infection with an unusual clinical presentation: A single-center case series
8. Skin and soft tissue infections in solid organ transplants
9. Recent advances in cytomegalovirus infection management in solid organ transplant recipients
10. Donor-derived infections in solid organ transplant recipients
11. Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors
12. The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia
13. COVID-19 positive donor for solid organ transplantation
14. Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients
15. Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
16. Clinical characteristics and outcome of 125 polymicrobial bloodstream infections in hematological patients: an 11-year epidemiologic survey
17. Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study
18. Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management.
19. Prevention and treatment of recurrent cellulitis
20. Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
21. Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy
22. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients
23. Clinical evidence supporting cefiderocol for serious Acinetobacter baumannii infections
24. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge
25. Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study.
26. Prevention and Treatment of Respiratory Virus Infection
27. Prevalencia de enfermedad colorrectal en la endocarditis infecciosa por Enterococcus faecalis: resultados de un estudio multicéntrico observacional
28. Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
29. COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes
30. Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: the DALBADIA retrospective cohort study.
31. Skin and soft tissue infections in solid organ transplants
32. Antibody response and risk of reinfection over two years among the first wave of COVID-19 patients
33. Recent concepts in fungal involvement in skin and soft tissue infections
34. Inhaled Liposomal Antimicrobial Delivery in Lung Infections
35. Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
36. Gram-negative bacteria as a cause of mediastinitis after cardiac surgery
37. Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature
38. P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION.
39. Reduced prophylactic effect of tixagevimab–cilgavimab in patients with hematological malignancies and without antibody response after SARS‐COV‐2 vaccination
40. COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection
41. Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review
42. New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA)
43. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
44. Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study
45. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study
46. Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant
47. Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
48. The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia
49. ‘Post-COVID-19 syndrome and humoral response association after one year in vaccinated and unvaccinated patients’: authors' response
50. Perioperative antibiotic stewardship in the organ transplant setting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.